FDA Accelerated Approval For BMS’ Zenbexus
▫️The US Food and Drug Administration (FDA) Has Approved Bristol Myers Squibb’s Zenbexus (Iberdomide) in Combination With Daratumumab And Hyaluronidase-fihj And Dexamethasone (ZDd) For The Treatment of Adult Patients With Multiple Myeloma Who Have Received at Least One Prior Line of Therapy Including A Proteasome Inhibitor And An Immunomodulatory Agent.
@MedicalNoteBook
2
1August 17, 2026 130 1
